Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition

Executive Summary

Medco will become the largest specialty drug distributor in the U.S. through its proposed acquisition of Accredo, with combined sales of approximately $4.3 bil. in 2004

You may also be interested in...



Rite Aid To Gain Specialty Drug, Part D Platforms With PBM EnvisionRx

The drug store chain will purchase EnvisionRx, which serves over 21 million members and expects to manage 145 million pharmacy claims in 2015, for $2 billion in cash and stock.

Cost Containment For Specialty Products Is New Horizon For PBMs

Rising spending on specialty pharmaceuticals is creating a major business opportunity for pharmacy benefit managers, despite the sector's historical cost containment challenges

Cost Containment For Specialty Products Is New Horizon For PBMs

Rising spending on specialty pharmaceuticals is creating a major business opportunity for pharmacy benefit managers, despite the sector's historical cost containment challenges

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel